| Insurance Carrier | Facility/Professional | Modifier | Low Price | Median Price | High Price |
|---|
Oncology (ovarian), spheroid cell culture, poly (ADP-ribose) polymerase (PARP) inhibitors (niraparib, olaparib, rucaparib, velparib), tumor response prediction for each drug
| Insurance Carrier | Facility/Professional | Modifier | Low Price | Median Price | High Price |
|---|